Argyle Capital Management Inc. Abbott Laboratories Transaction History
Argyle Capital Management Inc.
- $250 Million
- Q4 2024
A detailed history of Argyle Capital Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Argyle Capital Management Inc. holds 3,905 shares of ABT stock, worth $494,802. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,905
Previous 3,850
1.43%
Holding current value
$494,802
Previous $438,000
0.68%
% of portfolio
0.18%
Previous 0.18%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,376Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$21.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.78 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.61 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.85 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $222B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...